New York’s Cannabis Control Board is slow-walking the start of the state’s retail legal-pot sales, possibly to next year. But we’ve already seen how limited are its ideas of public-health alerts. Posters on commuter trains advise that only those 21 and over may use the drug — and that you can’t consume it in public. Anyone walking through Gotham knows how well those’ve worked.
Search This Blog
Sunday, July 31, 2022
A couple with ties to a firm that’s been awarded hundreds of millions in Medicaid transportation contracts over the years has driven more than $300,000 combined into the campaign coffers of former Gov. Andrew Cuomo and current Gov. Kathy Hochul, records reviewed by The Post reveal.
A new study posted to the medRxiv* preprint server reported the outcomes of a clinical trial evaluating an oral vaccine candidate against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
By George Lei, Bloomberg Markets Live commentator and analyst
When one looks at New York City's recovery from the pandemic lockdowns, it's hard to make the case that things are going swimmingly. The city is re-opening at a snail's pace, with some blocks (like the recently profiled block near the 59th St. subway) still "frozen" in peak-pandemic time.
An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting condition 'stiff heart syndrome'.
Sen. Bill Cassidy (R-La.) on Sunday knocked the Inflation Reduction Act championed by Senate Majority Leader Charles Schumer (D-N.Y.) and centrist swing vote Sen. Joe Manchin (D-W.Va.), saying the bill could lead to a recession despite its sponsors’ claims that it will tamp down rising prices.
A dozen states have reported cases of the newest omicron subvariant BA.2.75 as of July 29, early disease surveillance data shows.
The subvariant has numerous mutations that may make it more adept than BA. 5, the nation's dominant strain, at spreading quickly and evading immune protection. While it's still unclear whether BA.2.75 will compete against BA.5 or cause more severe illness, some experts contend the subvariant is not the next big one to fret over.
Below is a breakdown of U.S. states reporting BA.2.75 cases, based on a dashboard run by Raj Rajnarayanan, PhD, assistant dean of research and associate professor in the department of basic sciences at the New York Institute of Technology College of Osteopathic Medicine at Arkansas State University in Jonesboro. The dashboard uses data from GISAID, a global data-sharing platform for viruses.
California — 10
Washington — 9
Illinois — 4
Virginia — 3
North Carolina — 3
Wisconsin — 2
New York — 2
Texas — 1
Nebraska — 1
Iowa — 1
Delaware — 1
Arizona — 1